RKV (RKV) News
Follow RKV (RKV) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 2 public stories across 2 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
L
Rakovina Therapeutics appoints Professor Petra Hamerlik to its board
Professor Petra Hamerlik, Chair of Translational Neuro-Oncology at the University of Manchester and previously a member of the company’s Scientific Advisory Board, was elected at Rakovina Therapeutics’ 2026 Annual Genera
EQUITY | Sep 10, 2026, 08:01 AM UTC
L
Rakovina Therapeutics Announces Q2 2026 Financial Results and Provides Corporate Update
Rakovina Therapeutics Announces Q2 2026 Financial Results and Provides Corporate Update
EARNINGS | Aug 31, 2026, 11:07 PM UTC